NUEMBERG, Germany, May 08, 2024–(BUSINESS WIRE)–Dr. Clauder’s joins forces with protein pioneer Calysta to launch world’s first dog treat made with FeedKind® Pet protein, a revolutionary new pet food ingredient.
Announced at the world’s leading pet trade fair, Interzoo, the groundbreaking air-dried treat presented by Dr. Clauder’s takes advantage of Calysta’s nutritionally rich protein, produced by natural fermentation – making it the perfect non-GMO ingredient that meets market demands for nutritional quality, palatability, and health for pets.
After its debut at Interzoo, the Dr. Clauder Trainee snack cultivated protein treats featuring FeedKind Pet, will be made available for sale in Europe.
FeedKind Pet protein is a fermented ingredient that is nutrient dense, has a complete amino acid profile for dogs, and has postbiotic properties that help maintain a healthy gut in animals. Additionally, FeedKind Pet is a vegan protein source.
Herman Sloot, vice president commercial development at Calysta said: “Dog owners have high expectations for their pet’s food and are increasingly aware of the origin, quality, and safety of the ingredients used.
“For the first time, the pet food sector in Europe has the option to choose a high-quality protein source that is nutritious and kind to the environment. Calysta is now produced on a significant scale, and FeedKind Pet has been approved for use in pet foods in the EU We are excited that Dr. Clauder’s is introducing a snack featuring FeedKind Pet protein as we set a new standard for dog treats – one that prioritizes taste and health, while protecting our planet.”
Alexander Gerards, Managing partner at Dr. solutions said. Clauder for pets: ”Novel proteins produced with respect for nature, which are vegetarian, nutritious and tasty are highly sought after. We’re happy that at FeedKind Pet we’ve created a dog treat that delivers just that: vegetarian, a complete amino acid profile and delicious. The Trainee Snack by Dr. Clauder’s cultivated proteins are a true innovation that meets the needs of the market.”
Alan Shaw, co-founder and CEO of Calysta said: “The global pet population is on the rise and there is little indication that it will slow down anytime soon. FeedKind Pet protein is a win for the pet sector and the consumer, offering optimal benefits for pets, owners and the planet. The first commercial launch of a petfood product in Europe containing FeedKind Pet is an exciting milestone for Calysta.”
For more information, visit feedkind.com and calysta.com.
About Calysta
Calysta, Inc., San Mateo, CA, is a biotechnology company working toward a future where a growing world population guarantees food security. Calysta’s goal is to produce protein without limitation by fermenting low-cost, soilless carbon sources, to create new feeds and food products, create sustainable, protein ingredients that add in the global food supply.
FeedKind®, the protein is produced with very little water and no agricultural land by fermenting low-cost, land-free carbon sources, to create a safe, nutritious, and traceable protein. Made by natural fermentation, it is non-GMO, has a complete amino acid profile, and is highly digestible. FeedKind Pet protein is now produced on a full commercial scale.
Dr. Clauder’s is a leading German-based brand dedicated to pet health, nutrition, and wellness, offering a comprehensive range of high-quality products for dogs and cats. In the ‘dream factory for dogs and cats,” they make premium pet foods and specialty supplements with high-quality ingredients. Dr. Clauder’s is trusted by pet owners and professionals for promoting the welfare of dogs and cats.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20240508551499/en/
Contacts
Calysta Press Office: [email protected]
Steven Flanagan, [email protected], (+44) 141 343 3250
Calysta Media info, [email protected]
